Louisbourg Investments Inc. Has $5.43 Million Holdings in Nutrien Ltd. $NTR

Louisbourg Investments Inc. lessened its position in Nutrien Ltd. (NYSE:NTR) by 14.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 72,059 shares of the company’s stock after selling 12,134 shares during the quarter. Louisbourg Investments Inc.’s holdings in Nutrien were worth $5,429,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Montag A & Associates Inc. boosted its holdings in Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares during the period. Sfam LLC bought a new position in shares of Nutrien in the fourth quarter worth about $37,000. Eastern Bank increased its stake in shares of Nutrien by 133.0% in the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after purchasing an additional 399 shares during the period. Harbour Investments Inc. lifted its position in shares of Nutrien by 97.2% during the 4th quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock worth $43,000 after purchasing an additional 347 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Nutrien by 42.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Stock Performance

Shares of NYSE:NTR opened at $61.09 on Friday. The stock has a market capitalization of $29.28 billion, a price-to-earnings ratio of 12.44, a price-to-earnings-growth ratio of 0.56 and a beta of 0.60. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. The business’s fifty day moving average price is $68.98 and its two-hundred day moving average price is $69.46. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36.

Nutrien (NYSE:NTR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.30 billion. During the same period in the previous year, the business earned $0.11 earnings per share. The company’s revenue for the quarter was up 18.5% compared to the same quarter last year. As a group, analysts predict that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be paid a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.6%. Nutrien’s dividend payout ratio (DPR) is 44.81%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on NTR. Royal Bank Of Canada raised their target price on Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, April 7th. Wells Fargo & Company upgraded Nutrien from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $77.00 to $100.00 in a report on Friday, March 13th. Barclays increased their price objective on Nutrien from $70.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. UBS Group lowered their price objective on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research note on Monday, May 11th. Finally, BMO Capital Markets boosted their target price on shares of Nutrien from $85.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 18th. Eleven equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $81.71.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.